About Index Trending news
Analyze
Top 50 Pricing
CellBioMedGroup

CellBioMedGroup

Work at CellBioMedGroup? Add yourself to this profile

CellBioMedGroup

Dedicated to using #biotechnology to develop treatment for #cancer and degenerative diseases in China $CBMG

Elsewhere

Alexa global traffic share

Twitter followers

Latest funding
Post-IPO equity
$43,130,000
Dangdai Science & Technology Industries Group
Venture capital
$6,907,995
Employees

Team size

2
Locations
HQ

No recent coverage

Index constantly checks hot and trending companies for their latest activity. We haven't gotten to this company yet, but if you follow it you'll be the the first to know when CellBioMedGroup makes some noise.